drugset / Trial / NCT07422207
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants
RandomizedSequentialQuadruple-blindBasic science
Summary
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants
Timeline
- Start
- 2026-03-23
- Primary completion
- 2027-07
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ME3241 | Unknown | — | Intravenous |
Indications
No indication recorded.